Haemonetics | HAE - Ebitda

Prix De L'Action
56.29
Variation Quotidienne
-0.83 -1.45%
Mensuellement
-6.36%
Annuel
-19.94%
Q2 Prévisions
53.98




Ebitda Changement Date
Avanos Medical USD 13M 3M 2025-12
Baxter International USD -447M 873M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Fresenius EUR 951M 283M 2026-03
Fresenius Medical Care EUR 824M 250M 2026-03
Globus Medical USD 280.46M 27.86M 2025-12
Haemonetics USD 94.78M 20.75M 2025-12
ICU Medical USD 98.68M 489K 2026-03
Intuitive Surgical USD 1.09B 165.5M 2025-12
Masimo USD 85.5M 6.4M 2026-03
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Neogen USD 48.2M 546K 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Plus Therapeutics USD -4.4M 2.94M 2025-09
Quidel USD 108.7M 44.6M 2026-03
ResMed USD 547.48M 27.46M 2025-12
STAAR Surgical USD -159K 34.78M 2025-12
Steris USD 394.7M 5M 2025-12
Stryker USD 1.57B 618M 2026-03
Surmodics USD 3.43M 1.9M 2025-06
Teleflex USD 247.07M 575.88M 2025-12
Terumo JPY 57.88B 12.1B 2026-03
Thermo Fisher Scientific USD 2.7B 464M 2026-03
US Physical Therapy USD 24.75M 899K 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12